Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
66,472,048
-
Shares change
-
+32,265,270
-
Total reported value, excl. options
-
$1,107,025,988
-
Value change
-
+$548,273,938
-
Put/Call ratio
-
47%
-
Number of buys
-
121
-
Number of sells
-
-62
-
Price
-
$16.65
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2023
230 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q1 2023.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,472,048 shares
of 113,177,462 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include FMR LLC (10,922,748 shares), STATE STREET CORP (5,280,944 shares), VANGUARD GROUP INC (4,058,639 shares), MILLENNIUM MANAGEMENT LLC (3,837,996 shares), BlackRock Inc. (2,040,278 shares), Boxer Capital, LLC (2,000,000 shares), VIKING GLOBAL INVESTORS LP (1,955,063 shares), WASATCH ADVISORS LP (1,705,444 shares), Laurion Capital Management LP (1,697,352 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,343,308 shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.